HSBC Holdings’s ChemoCentryx, Inc. CCXI Stock Holding History

HSBC Holdings’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-270,839	Closed	-$14M	–	3315
2022 Q3	$14M	Buy	+270,839	New	+$11.2M	0.02%	693
2021 Q1	–	Sell	-4,505	Closed	-$279K	–	3250
2020 Q4	$279K	Buy	+4,505	New	+$258K	﹤0.01%	2617
2019 Q4	–	Sell	-35,452	Closed	-$240K	–	3246
2019 Q3	$240K	Buy	+35,452	New	+$266K	﹤0.01%	2773

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HSBC Holdings's CCXI Position: Q4 2022 in Review

HSBC Holdings sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 270,839 shares — an estimated $14M sold.

HSBC Holdings first reported a position in CCXI in Q3 2019 and held it in 3 quarters. The position peaked at $14M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

HSBC Holdings reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
HSBC Holdings sold 270,839 ChemoCentryx, Inc. shares in Q4 2022, an estimated $14M.
HSBC Holdings first reported a position in ChemoCentryx, Inc. in Q3 2019 and held it in 3 quarters.
HSBC Holdings's ChemoCentryx, Inc. position peaked at $14M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on HSBC Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.